Maisha Meds

Maisha Meds is an organization dedicated to improving health care in Africa. We began full-time operations in 2017 and over the past few years has grown to support over 3million patient encounters annually across 1,000 clinics, pharmacies, and drug shops in Kenya, Tanzania, Uganda, and Nigeria. We are building the financial and technology infrastructure to enable global health funders to pay for health outcomes at the last mile, with a focus on malaria case management (and results from a RCT with UC Berkeley due out later this year), injectable contraceptives, prenatal care, HIV pre-exposure prophylaxis, and COVID testing and vaccination.

Our work is funded by USAID Development Innovation Ventures, the Bill & Melinda Gates Foundation, the Children’s Investment Fund Foundation, Grand Challenges Canada, Pfizer, and others, and we are starting to build partnerships with multilateral global health funders, pharmaceutical companies, and national health insurance funds. We use data from our point of sale software to design programs that leverage financial incentives to improve uptake of high impact health products. And we measure our success by our ability to improve the quality and affordability of healthcare diagnosis, treatment, and prevention for low-income patients across Africa.